Telomere Length and Telomerase Activity in Malignant Lymphomas
Author Information
Author(s): Remes K, Norrback K-F, Rosenquist R, Mehle C, Lindh J, Roos G
Primary Institution: University of Umeå
Hypothesis
The study investigates the telomere lengths and telomerase activity in malignant lymphomas at diagnosis and relapse.
Conclusion
Anti-telomerase therapy would be suitable in only a fraction of malignant lymphomas.
Supporting Evidence
- Significant telomere shortening was observed in diagnostic lymphomas compared to benign lymphoid tissues.
- Shortened, unchanged, and elongated telomere lengths were observed in relapse samples.
- Telomere length alterations in relapsing lymphomas appeared to represent clonal selection.
Takeaway
This study looked at how long the ends of chromosomes are in lymphoma patients and found that some patients might not benefit from a specific cancer treatment.
Methodology
Telomere lengths were studied in diagnostic lymphomas and consecutive samples from patients with relapsing non-Hodgkin's lymphomas.
Limitations
The study indicates that telomere length alterations in relapsing lymphomas are independent of telomerase activity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website